Almujtama Medical reveals details of e-commerce deal with Badayat Al-Amal

Almujtama Medical says agreement is divided into 2 operational phases

Almujtama Alraida Medical Co. clarified details of its e-commerce and marketing services agreement signed on Nov. 6 with Badayat Al-Amal for Trading Co., according to a Tadawul statement.

Under the agreement, Badayat Al-Amal will handle marketing, promotion, and sales of Almujtama Medical’s products through e-commerce channels.

Almujtama Medical will receive a fixed profit margin of 4% above the cost of goods, with no deductions. Any profits or losses exceeding this threshold (cost of goods sold + 4% profit) will belong entirely to Badayat Al-Amal, the statement added.

The agreement is effective from the signing date and will remain in force for an initial term of three years, in line with the mutually agreed commercial framework. It will automatically renew for successive one-year periods, unless either party provides written notice of non-renewal at least 90 days before the end of the current term.

Both parties also agreed that the contract will be implemented gradually in three phases, each with defined objectives, procedures, and milestones. Progression to the next phase will only happen after a comprehensive evaluation of operational, technical, and financial aspects, followed by official approval from both parties based on the results.

The financial impact of the agreement is likely to be reflected in the company’s 2026 financials, the statement said.